Research output per year
Research output per year
Personal profile
Research interests
I am interested in the role of fungal allergens in allergic rhinitis and asthma, particualrly with respect to the production of nasal cytokines. I am also interested in new treatment modalities for chronic urticaria as well as other atopic diseases.
Clinical interests
Asthma, urticaria, hives, children with asthma, infectious diseases, allergies, allergic diseases, immunological diseases, allergic reactivity, allergic conjunctivitis, articulation of asthma, eosinophilia, usage of antibodies, immunochemistry, lymphocyte activation, development of immunities, clinical immunology, chronic fatigue syndrome, fungal allergies, environmental control for allergies
Fingerprint
Dive into the research topics where James Wedner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study
for the HELP OLE Investigators, Mar 2022, In: Allergy: European Journal of Allergy and Clinical Immunology. 77, 3, p. 979-990 12 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Scopus citations -
Optimization of care for patients with hereditary angioedema living in rural areas
Riedl, M. A., Johnston, D. T., Anderson, J., Meadows, J. A., Soteres, D., LeBlanc, S. B., Wedner, H. J. & Lang, D. M., May 2022, In: Annals of Allergy, Asthma and Immunology. 128, 5, p. 526-533 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study
HELP Study Investigators, Oct 2021, In: Clinical and Experimental Allergy. 51, 10, p. 1391-1395 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study
on behalf of the HELP Study Investigators, Apr 2021, In: Allergy: European Journal of Allergy and Clinical Immunology. 76, 4, p. 1188-1198 11 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations -
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
SYNAPSE study investigators, Oct 2021, In: The Lancet Respiratory Medicine. 9, 10, p. 1141-1153 13 p.Research output: Contribution to journal › Article › peer-review
112 Scopus citations